Skip to content
10-Q

Quarterly Report

Vanda Pharmaceuticals Inc. VNDA

0001628280-25-036861

← back to feed
Filed
Jul 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 24, 2025 59.09M sh
Shares Diluted Q2 2025 · Jun 30, 2025 58.99M sh
Shares Diluted Q2 2025 · Jun 30, 2025 58.76M sh
Shares Diluted Q2 2025 · Jun 30, 2024 58.22M sh
Shares Diluted Q2 2025 · Jun 30, 2024 57.99M sh
Capex Q2 2025 · Jun 30, 2025 $735K
Capex Q2 2025 · Jun 30, 2024 $115K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$48.4M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $641K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $80.98M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $102.32M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $102.95M
Stockholders Equity Q2 2025 · Jun 30, 2025 $486.33M
Stockholders Equity Q2 2025 · Mar 31, 2025 $511.42M
Stockholders Equity Q2 2025 · Dec 31, 2024 $538.55M
Stockholders Equity Q2 2025 · Jun 30, 2024 $542.52M
Stockholders Equity Q2 2025 · Mar 31, 2024 $544M
Stockholders Equity Q2 2025 · Dec 31, 2023 $544.91M
Current Liabilities Q2 2025 · Jun 30, 2025 $121.49M
Current Liabilities Q2 2025 · Dec 31, 2024 $99.98M
Total Liabilities Q2 2025 · Jun 30, 2025 $138.42M
Total Liabilities Q2 2025 · Dec 31, 2024 $117.66M
Current Assets Q2 2025 · Jun 30, 2025 $394.92M
Current Assets Q2 2025 · Dec 31, 2024 $438.89M
Total Assets Q2 2025 · Jun 30, 2025 $624.75M
Total Assets Q2 2025 · Dec 31, 2024 $656.2M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.46
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.96
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.08
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.15
Eps Basic Q2 2025 · Jun 30, 2025 −$0.46
Eps Basic Q2 2025 · Jun 30, 2025 −$0.96
Eps Basic Q2 2025 · Jun 30, 2024 −$0.08
Eps Basic Q2 2025 · Jun 30, 2024 −$0.15
Sga Expense Q2 2025 · Jun 30, 2025 $64.62M
Sga Expense Q2 2025 · Jun 30, 2025 $114.7M
Sga Expense Q2 2025 · Jun 30, 2024 $39.47M
Sga Expense Q2 2025 · Jun 30, 2024 $69.56M
Rd Expense Q2 2025 · Jun 30, 2025 $21.99M
Rd Expense Q2 2025 · Jun 30, 2025 $57.7M
Rd Expense Q2 2025 · Jun 30, 2024 $16.66M
Rd Expense Q2 2025 · Jun 30, 2024 $37.82M
Net Income Q2 2025 · Jun 30, 2025 −$27.21M
Net Income Q2 2025 · Jun 30, 2025 −$56.7M
Net Income Q2 2025 · Mar 31, 2025 −$29.49M
Net Income Q2 2025 · Jun 30, 2024 −$4.52M
Net Income Q2 2025 · Jun 30, 2024 −$8.66M
Net Income Q2 2025 · Mar 31, 2024 −$4.15M
Operating Income Q2 2025 · Jun 30, 2025 −$38.5M
Operating Income Q2 2025 · Jun 30, 2025 −$79.53M
Operating Income Q2 2025 · Jun 30, 2024 −$10.15M
Operating Income Q2 2025 · Jun 30, 2024 −$19.38M
Revenue Q2 2025 · Jun 30, 2025 $52.59M
Revenue Q2 2025 · Jun 30, 2025 $102.63M
Revenue Q2 2025 · Jun 30, 2024 $50.47M
Revenue Q2 2025 · Jun 30, 2024 $97.94M